Home » Authors » James Etheridge

Articles by James Etheridge

Ricerca Begins Cancer Portfolio, Licenses Genset’s RAP-3 Gene

March 20, 2002

By James Etheridge

Galapagos Genomics Closes $18.7M Initial Funding Round

March 13, 2002

By James Etheridge

Galapagos Genomics Closes $18.7M Initial Funding Round

March 13, 2002

By James Etheridge

Genset Sells Division, Secures Equity Line Of Up To EUR30M

March 6, 2002

By James Etheridge

Innate Pharma Seeking $13M To Develop Cancer Therapies

March 6, 2002

By James Etheridge

Innate Pharma Seeking $13M To Develop Cancer Therapies

March 6, 2002

By James Etheridge

Genset Sells Division, Secures Equity Line Of Up To EUR30M

March 6, 2002

By James Etheridge

French Challenge Another Myriad Patent On Breast Cancer Gene

Feb. 27, 2002

By James Etheridge

French Challenge Another Myriad Patent On Breast Cancer Gene

Feb. 27, 2002

By James Etheridge

Sanofi-Synthélabo Selects Melanoma Vaccine From IDM

Feb. 20, 2002

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 12, 2024.
Second insulin receptor offers new therapeutic avenues
BioWorld Science
Investigators at the Helmholtz Institute have shown that inceptor, an inhibitor of the insulin signaling pathway, acted by binding insulin and targeting it for...
KITE-753, a rapid manufactured CAR T therapy with superior antitumor efficacy and enhanced expansion in vivo
BioWorld Science
In a presentation at the recent American Society of Hematology meeting in San Diego, Kite Pharma Inc. reported preclinical data for KITE-753, an autologous rapid...
Keros stock wilts as it halts two dosing arms in hypertension study
BioWorld
After Keros Therapeutics Inc.’s voluntary halt of dosing in two arms of its phase II study in pulmonary arterial hypertension, the company’s stock crumpled after...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.